Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Glia. 2020 Jan 16;68(7):1347–1360. doi: 10.1002/glia.23779

TABLE 1.

Antibody details

Antibody Manufacturer Method Dilution
Rb anti-leukotriene B4 receptor 1 (BLT1) Cayman Chemical, Ann Arbor, MI Immunoblot 1:1,000
Ms anti-chemokine-like receptor 1 (ChemR23) Santa Cruz Biotechnology, Dallas, TX Immunoblot 1:200
Rb anti-Peroxisome proliferator-activated receptor gamma (PPAR-γ) R&D Systems, Minneapolis, MN Immunoblot 1:1,000
Rb anti-N-formyl peptide receptor 2 (LxA4R) Santa Cruz Biotechnology, Dallas TX Immunoblot 1:500
Rb anti-phospho (Thr202/Tyr204) extracellular-signal-regulated kinase (Erk1/2) Cell Signaling, Danvers, MA Immunoblot 1:1,000
Ms anti-total extracellular-signal-regulated kinase (Erk1/2) Cell Signaling, Danvers, MA Immunoblot 1:1,000
Rb anti-15-lipoxygenase-2 (15LOX2) Cayman Chemical, Ann Arbor, MI Immunoblot 1:200
Rb anti-calbindin-D28 Bio-Rad, Hercules, CA Immunoblot 1:200
Rb anti-ionized calcium binding adaptor molecule 1 (Iba1) MilliporeSigma, Burlington, MA Immunohistochemistry 1:200
Rb anti-protein tyrosine phosphatase, receptor type, C (CD45) Wako-Chem, Richmond, VA Immunohistochemistry 1:200